BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37141766)

  • 1. The biogenesis of the immunopeptidome.
    Admon A
    Semin Immunol; 2023 May; 67():101766. PubMed ID: 37141766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are There Indeed Spliced Peptides in the Immunopeptidome?
    Admon A
    Mol Cell Proteomics; 2021; 20():100099. PubMed ID: 34022431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC Class I Immunopeptidome: Past, Present, and Future.
    Yewdell JW
    Mol Cell Proteomics; 2022 Jul; 21(7):100230. PubMed ID: 35395404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nature and extent of contributions by defective ribosome products to the HLA peptidome.
    Bourdetsky D; Schmelzer CE; Admon A
    Proc Natl Acad Sci U S A; 2014 Apr; 111(16):E1591-9. PubMed ID: 24715725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Game of Omes: ribosome profiling expands the MHC-I immunopeptidome.
    Holly J; Yewdell JW
    Curr Opin Immunol; 2023 Aug; 83():102342. PubMed ID: 37247567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-Scale Immunopeptidome Analysis Reveals Recurrent Posttranslational Splicing of Cancer- and Immune-Associated Genes.
    Levy R; Alter Regev T; Paes W; Gumpert N; Cohen Shvefel S; Bartok O; Dayan-Rubinov M; Alon M; Shmueli MD; Levin Y; Merbl Y; Ternette N; Samuels Y
    Mol Cell Proteomics; 2023 Apr; 22(4):100519. PubMed ID: 36828127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Interferons on Presentation of Defective Ribosomal Products as HLA Peptides.
    Komov L; Melamed Kadosh D; Barnea E; Admon A
    Mol Cell Proteomics; 2021; 20():100105. PubMed ID: 34087483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unexplored angle: T cell antigen discoveries reveal a marginal contribution of proteasome splicing to the immunogenic MHC class I antigen pool.
    Verkerk T; Koomen SJI; Fuchs KJ; Griffioen M; Spaapen RM
    Proc Natl Acad Sci U S A; 2022 Jul; 119(29):e2119736119. PubMed ID: 35858315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical Review of Existing MHC I Immunopeptidome Isolation Methods.
    Kuznetsov A; Voronina A; Govorun V; Arapidi G
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33228004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spliced HLA-bound peptides: a Black Swan event in immunology.
    Faridi P; Dorvash M; Purcell AW
    Clin Exp Immunol; 2021 May; 204(2):179-188. PubMed ID: 33644851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of immunopeptidomics: From basic research to clinical implementation.
    Shapiro IE; Bassani-Sternberg M
    Semin Immunol; 2023 Mar; 66():101727. PubMed ID: 36764021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accurate MHC Motif Deconvolution of Immunopeptidomics Data Reveals a Significant Contribution of DRB3, 4 and 5 to the Total DR Immunopeptidome.
    Kaabinejadian S; Barra C; Alvarez B; Yari H; Hildebrand WH; Nielsen M
    Front Immunol; 2022; 13():835454. PubMed ID: 35154160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERAP1 enzyme-mediated trimming and structural analyses of MHC I-bound precursor peptides yield novel insights into antigen processing and presentation.
    Li L; Batliwala M; Bouvier M
    J Biol Chem; 2019 Dec; 294(49):18534-18544. PubMed ID: 31601650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma.
    Faridi P; Woods K; Ostrouska S; Deceneux C; Aranha R; Duscharla D; Wong SQ; Chen W; Ramarathinam SH; Lim Kam Sian TCC; Croft NP; Li C; Ayala R; Cebon JS; Purcell AW; Schittenhelm RB; Behren A
    Cancer Immunol Res; 2020 Oct; 8(10):1322-1334. PubMed ID: 32938616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERAP1 shapes just part of the immunopeptidome.
    Admon A
    Hum Immunol; 2019 May; 80(5):296-301. PubMed ID: 30849449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of proteasome inhibition on the generation of the human leukocyte antigen (HLA) peptidome.
    Milner E; Gutter-Kapon L; Bassani-Strenberg M; Barnea E; Beer I; Admon A
    Mol Cell Proteomics; 2013 Jul; 12(7):1853-64. PubMed ID: 23538226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFNγ Modulates the Immunopeptidome of Triple Negative Breast Cancer Cells by Enhancing and Diversifying Antigen Processing and Presentation.
    Goncalves G; Mullan KA; Duscharla D; Ayala R; Croft NP; Faridi P; Purcell AW
    Front Immunol; 2021; 12():645770. PubMed ID: 33968037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases.
    Vizcaíno JA; Kubiniok P; Kovalchik KA; Ma Q; Duquette JD; Mongrain I; Deutsch EW; Peters B; Sette A; Sirois I; Caron E
    Mol Cell Proteomics; 2020 Jan; 19(1):31-49. PubMed ID: 31744855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The major histocompatibility complex class I immunopeptidome of extracellular vesicles.
    Synowsky SA; Shirran SL; Cooke FGM; Antoniou AN; Botting CH; Powis SJ
    J Biol Chem; 2017 Oct; 292(41):17084-17092. PubMed ID: 28860189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benchmarking Bioinformatics Pipelines in Data-Independent Acquisition Mass Spectrometry for Immunopeptidomics.
    Shahbazy M; Ramarathinam SH; Illing PT; Jappe EC; Faridi P; Croft NP; Purcell AW
    Mol Cell Proteomics; 2023 Apr; 22(4):100515. PubMed ID: 36796644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.